Table 4 Comparison of the long-term outcomes of the two groups
Outcome | Before PSM | |||
|---|---|---|---|---|
LAP (N = 106) | NOSES (N = 106) | χ2 | P value | |
Status at the last follow-up (N%) | 0.493 | 0.483 | ||
Survival | 84 (79.2%) | 88 (83.0%) | ||
Dead | 22 (20.8%) | 18 (17.0%) | ||
Local recurrence (N%) | 6 (5.7%) | 7 (6.6%) | 0.082 | 0.775 |
Distant metastasis (N%) | 8 (7.5%) | 8 (7.5%) | 0.000 | 1.00 |
Liver metastasis | 5 (4.7%) | 4 (3.8%) | / | |
Lung metastasis | 3 (2.8%) | 4 (3.8%) | / | |